PT  - JOURNAL ARTICLE
AU  - Cunningham, Muriel
ED  - Abdul-Ghani, Muhammad
TI  - Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes
DP  - 2013 Sep 01
TA  - MD Conference Express
PG  - 11--12
VI  - 13
IP  - 11
4099  - http://mdc.sagepub.com/content/13/11/11.2.short
4100  - http://mdc.sagepub.com/content/13/11/11.2.full
AB  - This article discusses the results of the Durability of Combination Therapy With Exenatide/Metformin Versus Conventional Therapy in New Onset T2DM study [NCT01107717] that evaluated the effects of a triple-therapy regimen versus stepwise add-on conventional therapy in patients with newly diagnosed type 2 diabetes. In this open-label study, 155 patients were randomized to triple therapy or stepwise add-on conventional therapy, with a goal of achieving an HbA1C of <6.5%.